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The type VII secretion system ESX-5 is a major pathway for
export of PE and PPE proteins in pathogenic mycobacteria.
These mycobacteria-specific protein families are characterized
by conserved N-terminal domains of 100 and 180 amino acids,
which contain the proline-glutamic acid (PE) and proline-pro-
line-glutamic acid (PPE) motifs after which they are named.
Herewe investigated secretion of the triacylglycerol lipase LipY,
which in fast-growing mycobacteria contains a signal sequence,
but in slow-growing species appears to have replaced the signal
peptide with a PE or PPE domain. Selected LipY homologues
were expressed in wild-type Mycobacterium marinum and its
corresponding ESX-5 mutant, and localization of the proteins
was investigated by immunoblotting and electron microscopy.
Our study shows that Mycobacterium tuberculosis PE-LipY
(LipYtub) and M. marinum PPE-LipY (LipYmar) are both
secreted to the bacterial surface in anESX-5-dependent fashion.
After transport, the PE/PPE domains are removed by proteo-
lytic cleavage. In contrast, Mycobacterium gilvum LipY, which
has a signal sequence, is not transported to the cell surface. Fur-
thermore, we show that LipYtub and LipYmar require their
respective PE and PPE domains for ESX-5-dependent secretion.
The role of the PE domain in ESX-5 secretion was confirmed in
a whole cell lipase assay, in which wild-type bacteria expressing
full-length LipYtub, but not LipYtub lacking its PE domain, were
shown to hydrolyze extracellular lipids. In conclusion, both PE
and PPE domains contain a signal required for secretion of LipY
by the ESX-5 system, and these domains are proteolytically
removed upon translocation.
Mycobacteria such asMycobacterium tuberculosis, the etio-
logical agent of tuberculosis, have a highly unusual and complex
cell envelope (1). To secrete virulence factors across the cell
envelope, these bacteria use specialized protein secretion sys-
tems, known as ESXor typeVII secretion systems (2–8).Myco-
bacterial genomes contain up to five genetic loci coding for type
VII secretion systems, named ESX-1 to ESX-5 (9, 10). Themost
well studied system, ESX-1, is responsible for the secretion of 10
substrates, including the importantT-cell antigens ESAT-6 and
CFP-10, and is required for full virulence ofM. tuberculosis (7,
11–17). Phylogenetic analyses and comparative genomics sug-
gest that the five ESX clusters have evolved by gene duplication
and that ESX-5 is the result of themost recent duplication event
(9). Interestingly, ESX-5 is restricted to a group of mycobacte-
rial species known as the slow-growing mycobacteria, which
include all major pathogens, such asM. tuberculosis,Mycobac-
terium leprae, andMycobacteriumulcerans, and the fish patho-
genMycobacteriummarinum (9). Four of the ESX loci contain
also PE and PPE genes (named after the conserved Pro-Glu (PE)
and Pro-Pro-Glu (PPE) motifs near the N termini of their
respective gene products) (9, 10), and the appearance of ESX-5
predates the huge expansion of these gene families in slow-
growing mycobacteria (18). Intriguingly, although fast-grow-
ing, non-pathogenic mycobacteria encode only a small number
of PE and PPE proteins, pathogens such as M. marinum and
M. tuberculosis dedicate nearly 10% of the coding potential of
their genomes tomembers of the PE andPPE gene families (19).
Although the precise function of these proteins is largely
unknown, members of both families are important for myco-
bacterial virulence (20–24).Moreover, various PE andPPEpro-
teins are located on the cell surface, where they can interact
with the host during infection (21, 25–28). However, because
the PE and PPE proteins lack detectable secretion signals, the
route of translocation across the cell envelope remained
unclear untilmembers of the two protein families were recently
shown to be secreted by the ESX-5 system in M. marinum (3,
29).
PE and PPE proteins are characterized by unrelated, con-
served N-terminal domains2 of 100 (PE) and 180 (PPE)
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amino acids (aa) (19), and they can be divided into different
subfamilies on the basis of their C-terminal domains (19, 30,
31). To date, little is known about the function of the various
domains of the PE and PPE proteins. In fact, theM. tuberculosis
PE protein LipY (hereafter referred to as LipYtub) is the only PE
protein for which a function has been characterized (32).
M. tuberculosisLipYtub is involved in the degradation of triacyl-
glycerols (TAGs) and is the major active lipase under nutrient-
deprived conditions. This led to the hypothesis that LipYtub
plays a role in fatty acid metabolism during the dormancy and
reactivation stages of the M. tuberculosis infection cycle (32).
Although the lipolytic activity of LipYtub is expressed by the
C-terminal part of the protein (32), the function of its N-termi-
nal PE domain is less clear. It has been shown that the PE
domain of LipYtub has an inhibiting effect on the lipase activity
(33). Furthermore, cell wall and cell surface localization of LipY
was shown to occur independently of the presence of the PE
domain (33). Similar results were obtained for M. marinum
LipY (hereafter referred to as LipYmar), which contains a PPE
domain instead of a PE domain. These results contradict those
obtained in Refs. 26 and 27, which showed that localization of
heterologously expressed PE_PGRS33 (member of the poly-
morphic GC-rich repetitive sequence subfamily of PE proteins)
in the cell wall of Mycobacterium smegmatis is dependent on
the PE domain.
In this study, we show that, like many other PE and PPE
proteins, the M. tuberculosis and M. marinum LipY homo-
logues are secreted byESX-5.Using a combination ofmolecular
techniques and analysis of the lipolytic activity of LipY,we show
that ESX-5-mediated secretion of the LipY homologues is
dependent on the respective PE and PPE domains.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions—M. marinum
wild-type strains E11 (34) and Mvu (35) and their respective
ESX-5 mutants 7C1 (29) and Mx2 (3) and Mycobacterium gil-
vum PYR-CGK (ATCC 700033) (36) were grown at 30 °C with
shaking at 90 rpm, whereas Mycobacterium bovis bacille
Calmette-Gue´rin (BCG) Copenhagen (37), M. bovis BCG Tice
(38), andM. tuberculosismc26020 (39) were grown standing at
37 °C.M. smegmatismc2155 (40) was grown at 37 °Cwith shak-
ing at 90 rpm. All mycobacterial strains were grown inMiddle-
brook 7H9 broth (Difco-BD Biosciences), supplemented with
Middlebrook ADC and 0.05% Tween 80 (Sigma-Aldrich). In
secretion experiments, mycobacteria were grown to mid-loga-
rithmic phase, at which they were washed to remove BSA (part
of the ADC supplement) and subsequently grown in Middle-
brook 7H9 supplemented with 0.2% dextrose and 0.05% Tween
80 for another 24 h. If cultures were grown for electroporation,
glycine was added to a final concentration of 2.5 mg/ml during
the early exponential phase to increase electroporation effi-
ciency (3). Transformants were selected onMiddlebrook 7H10
agar plates and supplemented with Middlebrook OADC and
appropriate antibiotics. Escherichia coli DH5 was grown at
37 °C in LB medium (Difco-BD Biosciences) for cloning exper-
iments. Hygromycin was used at a concentration of 50 g/ml
for mycobacteria and 100 g/ml for E. coli, and kanamycin was
used at a concentration of 25 g/ml.
Plasmid Construction—All DNAmanipulations were carried
out according to standard protocols. Pfu DNA polymerase,
restriction enzymes, and T4 DNA ligase were purchased from
Fermentas. Chromosomal DNA from M. marinum E11 and
M. gilvum PYR-CGK was used as template in PCR reactions.
Plasmids and primers are described in supplemental Tables S1
and S2, respectively.
Cloning of Rv3097c (gene encoding LipYtub), modified to
express a C-terminal HA tag, in the E. coli-mycobacterial shut-
tle vector pMV10–25 to generate pAL36 is described in Ref. 26.
pMV10–25 contains a minimal pAL5000 origin of replication,
which lacks orf5 that is required for initiating stable replication
(41). Therefore, a 1749-bp fragment containing the hsp60 pro-
moter sequence, the Rv3097c gene, and the in-frame sequence
encoding anHA tag followed by a stop codonwas isolated from
pAL36 by digestion with HindIII and XbaI. The fragment was
ligated into the pSMT3 vector (42), which contains a full
pAL5000 origin of replication, digested with HindIII and XbaI,
to generate pSMT3::LipYtub. To construct pSMT3::LipYtub-
PE, a gene fragment encoding LipYtub without the first 125 aa
was amplified from pAL36, cloned in pMV10–25 to generate
pAL45, and subsequently transferred to pSMT3 by digestion
with HindIII and XbaI.
For cloning of sequences encoding LipYmar and LipYgilv or
truncated forms of LipYtub and LipYmar, forward primers were
designed to contain an NheI site immediately upstream of the
start codon, and reverse primers contained anHA tag encoding
sequence in-frame with the coding sequence, a stop codon, and
a BamHI or BglII site. PCR fragments were inserted into
pSMT3::LipYtub, digested with NheI and BamHI, thereby
replacing the Rv3097c gene and HA-encoding sequence.
Plasmids for expression of fusions of LipYtub and LipYgilv
were generated as follows. To replace the PE domain of LipYtub
with the signal peptide of LipYgilv, a 145-bp fragment encoding
the signal sequence was amplified from M. gilvum chromo-
somalDNAanddigestedwithNheI andEcoRI. Then, a 1045-bp
fragment coding for the linker and lipase domains of LipYtub
and the HA tag was isolated from pSMT3::LipYtub by diges-
tion with EcoRI and XbaI. The two fragments were ligated
into pSMT3, digested with NheI and XbaI, to generate
pSMT3::SPgilv-LipYtub. For the construct in which the signal
peptide of LipYgilv was replaced by the PE domain of LipYtub, a
309-bp fragment encoding the LipYtub PE domain was isolated
from pSMT3::LipYtub by digestion with NheI and EcoRI. In
addition, a 1390-bp fragment encoding the linker and lipase
domains of LipYgilv and the HA sequence was amplified from
M. gilvum chromosomal DNA and digested with EcoRI and
BglII. These two fragments were ligated into a 5691-bp NheI-
BamHI fragment of pSMT3::LipYtub, replacing the Rv3097c
gene, resulting in the pSMT3::PEtub-LipYgilv vector. For the
fusion of the PE and linker domains of LipYtub to the lipase
domain of LipYgilv, a nested PCR approachwas taken to amplify
fragments from the pSMT3::LipYtub and pSMT3::LipYgilv vec-
tors. After digestion with NheI and BamHI, the resulting
1436-bp fragment was inserted into pSMT3::LipYtub, as
described above, to generate pSMT3::PE/linkertub-LipYgilv.
Because M. tuberculosis mc26020 carries a hygromycin
resistance marker (39), LipYtub was placed under control of the
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hsp60 promoter in the pBH10 vector (3, 43). A 1355-bp frag-
ment containing Rv3097c, the in-frame HA sequence, and the
stop codon was cut out from pSMT3::LipYtub with BspEI and
BamHI, and ligated into pBH10 digested with the same
enzymes. The constructs were verified by sequencing.
Site-directed Mutagenesis of the LipYtub Cleavage Site—De-
rivatives of pSMT3::LipYtub containing point mutations were
generated using the QuikChange site-directed mutagenesis kit
(Stratagene). Because pSMT3::LipYtub was too large for the Pfu
Turbo DNA polymerase to amplify, the smaller pAL36 was
used as template. The 1749-bp HindIII-XbaI fragments con-
taining the hsp60 promoter and the mutated gene were trans-
ferred into pSMT3 as described above. The mutations were
verified by sequencing.
SDS-PAGE and Immunoblotting—Mycobacterial cells
grown to mid-logarithmic phase were separated from culture
supernatants by centrifugation. The cells were washed with
PBS and thereafter disrupted by sonication. Surface-exposed
proteins were isolated by incubating intact cells with 0.5%
Genapol X-080 (v/v; Sigma-Aldrich) for 30 min at room tem-
peraturewith head-over-head rotation, prior to sonication (26).
Secreted proteins were precipitated from culture supernatants
with 10% TCA (w/v; Sigma-Aldrich). Protein samples were
boiled, separated by SDS-PAGE, and thereafter transferred to
nitrocellulose membranes (Amersham Biosciences) by West-
ern blotting. The membranes were incubated with mouse
monoclonal antibodies directed against the influenza hemag-
glutinin epitope (HA.11; Covance), GroEL2 (CS44; JohnBelisle,
National Institutes of Health, Bethesda, MD, Contract
AI-75320) or ESAT-6 (Hyb 76-8; Statens Serum Institut,
Copenhagen, Denmark) or with rabbit polyclonal serum recog-
nizing PPE41 (3). Secondary horseradish peroxidase conju-
gated goat anti-mouse IgGs (A106PS, American Qualex) or
goat anti-rabbit IgGs (611-1302, Rockland) were detected
with 4-chloronaphtol/3,3-diaminobenzidine staining or ECL
(Pierce).
N-terminal Sequencing—To identify the LipYtub processing
site, we determined the N-terminal amino acid sequence of the
cleaved form of the protein. Surface-exposed proteins were
extracted with Genapol as described above and separated by
SDS-PAGE. Proteins were transferred to a PVDF membrane
(Millipore) and stained with 0.1% Coomassie Brilliant Blue
R-250 (Bio-Rad) in 1% acetic acid, 40%methanol. After destain-
ing with 50% methanol, the band corresponding to processed
LipYtub was cut out from the membrane, and the sequence of
the first seven amino acids was determined by Edman degrada-
tion (Eurosequence, Groningen, The Netherlands).
Immunogold Electron Microscopy (EM)—Fixation of bacte-
rial cells and immunogold labeling of whole cells were done as
described in Ref. 17. The HA.11 mouse monoclonal (Covance)
was used to visualize the HA-tagged LipY homologues.
Lipase Activity Assay—The lipolytic activity of surface-ex-
posedLipYtubwas analyzedwith amodifiedmethodof the assay
described in Ref. 33. IntactM. marinum cells grown in the dark
(to prevent production of yellow pigment that might interfere
with the absorbance measurements) were centrifuged, and an
equivalent of 1 OD unit was resuspended in Tris-HCl buffer
(100 mM, pH 8.0). p-Nitrophenyl stearate was added from a 20
mM stock solution prepared in isopropyl alcohol to reach a final
concentration of 0.5 mM in 200 l, and the mixture was vor-
texed and incubated for 15min at 37 °C. Thereafter the bacteria
were centrifuged, and the supernatant was transferred to a
96-well plate before measuring the production of p-nitrophe-
nol with a spectrophotometer at 405 nm. Reactions were car-
ried out in triplicate.
Bioinformatic Analyses—Nucleotide and protein sequences
were retrieved from theMarinoList, TubercuList, andNational
Center for Biotechnology Information (NCBI) databases. Lin-
ear genomic comparisons were performed with the Artemis
Comparison Tool software release 9 (44), with a cutoff value of
100 bp.
Cells Lines and Culture Conditions—For LipY macrophage
infection experiments, the human acute pro-monocytic leuke-
mia THP-1 cell line was used. Cells were cultured in RPMI 1640
withGlutamax-1medium (Invitrogen) supplementedwith 10%
FCS, streptomycin, and penicillin and differentiated into mac-
rophage-like cells in the presence of 10 ng/ml phorbol 12-my-
ristate 13-acetate (Sigma-Aldrich).
LipY Processing byMycobacteria inMacrophages—For infec-
tion, THP-1 cells were used between passage 13 and 20. Cells
were seeded at 10  106 per flask in 75-cm2 diameter flasks.
Mononuclear cells (3–5 107) were infected withM. tubercu-
losis or M. bovis BCG (multiplicity of infection 10) and incu-
bated for 3 h at 37 °C and 5% CO2. The supernatant was
removed, and the infected cells were washed three times with
medium to remove extracellular bacteria. Subsequently, the
cells were incubated in fresh medium with 10% FCS at 37 °C
and 5% CO2 for the indicated time periods. Enrichment of
mycobacterial proteins was performed as follows. Briefly,
infectedTHP-1 cells were collected andwashed twicewith PBS.
Cellularmembraneswere solubilized by treatmentwith 1%Tri-
tonX-100 for 15min at room temperature. Intactmycobacteria
were sedimented at 25,000  g for 30 min and subsequently
disrupted by sonication. Proteinswere separated by SDS-PAGE
and visualized by immunoblotting using the HA.11 mouse
monoclonal (Covance).
RESULTS
Homologues of LipY Have Evolved Different N-terminal
Domains—M. tuberculosis LipY consists of three domains: a
typical PE domain at the N terminus followed by a linker
domain of unknown function and a C-terminal domain con-
taining the triacylglycerol lipasemotif (for a schematic view, see
Fig. 1A). Nearly identical orthologues of LipYtub are found in
various other species of the M. tuberculosis complex, such as
M. bovis. However, with the exception of a pseudogene in
M. leprae (32), only one orthologue has been reported in a
mycobacterial species outside the M. tuberculosis complex
(33). This gene is present in M. marinum and codes for a pro-
tein with a different domain organization. Remarkably, al-
though the linker and lipase domains of LipYmar are 65% iden-
tical to LipYtub, the N-terminal PE domain is replaced by a PPE
domain (Fig. 1A).
We performed a BLAST search to identify additional homo-
logues of LipY in mycobacterial species. Two lipY copies were
found in Mycobacterium kansasii. Interestingly, one of these
PE and PPE Domains Target LipY Homologues to ESX-5
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has a PE domain (NCBI accession number ZP_04747303),
whereas the other has a PPE domain (NCBI accession number
ZP_04747310). The latter variant is probably not functional
because its lipase domain is disrupted by a stop codon so that
this PPE-LipY protein lacks the histidine residue of the Ser-
Asp-His catalytic triad. The two M. kansasii lipY genes are
located six genes apart in a region of conserved syntenywith the
sequences surrounding the lipY genes in M. tuberculosis and
M. marinum (Fig. 1B). Short stretches of non-homologous
DNA immediately up- and downstream of the lipY genes indi-
cate that some insertions and/or deletions have occurred in this
region. When the BLAST analysis was extended to the fast-
growing mycobacteria, two additional putative LipY proteins
were identified in M. gilvum (hereafter referred to as LipYgilv)
andMycobacterium vanbaalenii that shared 44 and 43% iden-
tity, respectively, with the C-terminal half of the linker domain
and the lipase domain of LipYtub (NCBI accession numbers
YP_001135683 and YP_952650). Strikingly, the N termini of
these sequences do not share homology with PE or PPE
domains but instead appear to contain classical signal peptides
(Fig. 1A), as indicated by SignalP analysis.
To gain insight in the evolutionary relationships between the
LipY homologues, a phylogenetic tree rooted to the Nocardia
farcinica lipase Nfa23150 (NCBI accession number YP_
118526) was constructed based on the conserved part of the
lipase domains, using the MEGA4 software (45) (not shown).
The tree topology is similar to that of themycobacterial species
tree, suggesting that the original lipY genewasmodified to con-
tain PE/PPE domains. The alignment tree also suggests that
PE-LipY evolved before PPE-LipY. This implies that the signal
sequence was initially replaced by a PE domain. Subsequently,
PE-LipY was (partially) duplicated and modified to contain an
N-terminal PPE domain.
LipYtub and LipYmar Are Substrates of ESX-5 inM.marinum—
Because several PE and PPE proteins have been shown to be
secreted by the ESX-5 secretion system (3, 29), we hypothesized
that the LipY homologues with PE/PPE domains are also ESX-5
substrates. To investigate this, the genes encoding LipYtub and
LipYmar were each cloned under control of the hsp60 promoter
andmodified to express a C-terminal HA tag (Fig. 1A). The two
constructs were subsequently introduced into wild-type
M. marinum strain E11 and its ESX-5 mutant derivative 7C1,
and the localization of the LipY-HA fusions was analyzed. Sur-
face-exposed proteins were extracted by treating intact cells
with the mild detergent Genapol X-080 (17, 26). For the wild-
type strain, a minor fraction of both LipYtub and LipYmar was
detected in the culture supernatant (Fig. 2, A and B, lane 4),
whereas substantial amounts of both proteins were detected in
the surface extracts (Fig. 2,A and B, lane 3). GroEL2 was absent
from the surface extracts and culture supernatants, confirming
the integrity of the cells. Furthermore, ESAT-6 was included in
the analysis as a positive control for secretion, and this protein
was normally secreted in all conditions. LipYtub and LipYmar
were undetectable in the surface extracts and culture superna-
tants of the ESX-5mutant (Fig. 2,A andB, lanes 7 and 8), which
confirms our hypothesis that these two proteins are substrates
of ESX-5. In addition, the LipY protein levels were markedly
lower in the ESX-5 mutant as compared with in the wild-type
lysates. Similar results have previously been obtained for the
ESX-5 substrates PPE41 and PE_PGRS (3, 29) and indicate that
when secretion is blocked, stability of the ESX-5 substrates is
affected. The ESX-5-dependent secretion and surface localiza-
tion of LipYtubwas confirmed inM. marinum strainMvu and its
ESX-5 mutant Mx2 (not shown).
In the total cell lysate of thewild-type strain expressing LipYtub,
two bands are detected (Fig. 2A, lane 1). The upper 40-kDa
FIGURE 1.Mycobacterial LipY homologues have evolved different N-ter-
minal domains. A, schematic representation of wild-type, truncated, and
chimeric forms of M. tuberculosis LipY (LipYtub), M. marinum LipY (LipYmar),
andM. gilvum LipY (LipYgilv). The PE, PPE, and signal peptide (SP) domains are
colored in shades of gray, the linker regions are colorless, and the lipase
domains areblack. TheHA tag is depictedas a stripedbox. Domainboundaries
are indicated for the wt proteins. B, comparisons of 30-kb regions surround-
ing the lipY genes, using the Artemis Comparison Tool, in the genomes of
M. tuberculosis,M. marinum, andM. kansasii. Conserved regions are shown in
gray, whereas homology within the lipY genes is represented in black. The
cut-off value for sequence homology was set to 100 bp.
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band likely represents the full-length protein, which has a
calculated molecular mass of 45.9 kDa, whereas the lower
band at 28 kDa probably represents an N-terminally pro-
cessed or degraded form. Only the smaller form is detectable
in the surface extract and in the culture supernatant (Fig. 2A,
lanes 3 and 4), whereas full-length LipYtub remains in the
FIGURE 2. LipYtub and LipYmar but not LipYgilv are secreted by ESX-5. A–D, immunoblot analysis of fractions containing equivalent OD units of cell pellets
(P), cells treatedwith themild detergentGenapol (P), proteins extracted from thebacterial surfacewithGenapol (S), and 2-foldmoreODunits of culture
supernatants (S ) from M. marinum wild-type E11 (wt) and ESX-5 mutant 7C1 (ESX-5::Tn) (A–C), or M. smegmatis strain mc2155 (D), expressing LipYtub (A),
LipYmar (B), and LipYgilv (C and D). LipY is detected with an antibody recognizing the HA epitope. GroEL2 is used as control for cell lysis, and ESAT-6 is used as
control for protein secretion. Processed forms of LipYtub and LipYmar are marked with arrowheads. E–J, whole bacteria fixed and probed with HA antiserum
followedby goat anti-mouse conjugate labeledwith 10-nmgold particles, analyzedwith EM to detect surface-exposed LipYtub (E and F), LipYmar (G andH), and
LipYgilv (I and J) inM. marinumwt E11 (E, G, and I) and the ESX-5 mutant 7C1 (F, H, and J). The scale bar represents 100 nm.
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Genapol-treated pellet and thus appears to be intracellular
(Fig. 2A, lane 2). In contrast, LipYtub was detected as a single,
40-kDa band in the total cell lysate of the ESX-5 mutant,
indicating that processing only occurs when LipYtub is
secreted (Fig. 2A, lane 5). For LipYmar, three bands are
detected, a minor band of 56 kDa probably representing full-
length LipYmar and two processed or degraded forms at 39
and 36 kDa (Fig. 2B, lane 1). As for LipYtub, only the full-
length band is detected in the ESX-5 mutant strain (Fig. 2B,
lane 5). However, unlike for LipYtub, all three forms are rep-
resented in the surface extract of the wild-type strain (Fig.
2B, lane 3).
To confirm the surface exposure of LipYtub and LipYmar, the
localization of the proteins was analyzed by immunogold EM
on whole cells. Wild-type cells expressing LipYtub were effi-
ciently labeled (Fig. 2E), whereas the ESX-5 mutant showed
little or no labeling (Fig. 2F), consistent with the immunoblot
results (Fig. 2A). Wild-type M. marinum expressing LipYmar
also showed surface labeling (Fig. 2G), although to a lesser
extent than LipYtub. Again, the ESX-5 mutant showed little or
no labeling (Fig. 2H), confirming that LipYmar is also secreted by
ESX-5. M. marinum harboring the empty plasmid showed no
reaction with the HA antiserum in immunoblots or whole cell
immunogold EM (not shown).
To investigate whether surface-exposed LipYtub is func-
tional, bacterial cells were incubated with p-nitrophenyl stea-
rate, after which the bacteria were removed by centrifugation.
Lipolytic activity resulted in the release of yellow p-nitrophenol
in the supernatants, which could be measured spectrophoto-
metrically. The wild-type strain expressing LipYtub showed
strongly increased activity as compared with the wild-type
strain harboring the empty plasmid pSMT3, confirming that
LipYtub is secreted to the cell surface where it is enzymatically
active (Fig. 3). Interestingly, the empty wild-type strain also
exhibited lipolytic activity, which was completely abolished in
the ESX-5 mutant strain, with or without lipY-containing plas-
mids. This activity could be due to chromosomally encoded
LipYmar.
LipYgilv Is Not Secreted in M.marinum or M. smegmatis—
The Sec-dependent secretion pathway in mycobacteria is, as in
other bacteria, responsible for translocation of proteins with
signal sequences across the inner membrane (4). Because LipYgilv
is predicted by the SignalP program to have a signal peptide,
we set out to determine its subcellular localization. To this end,
we amplified and cloned the lipYgilv gene with a C-terminal HA
tag under control of the hsp60 promoter (Fig. 1A). Upon intro-
duction intoM. marinumwild-type E11 and its ESX-5 mutant,
no bands could be detected in the culture supernatant or
Genapol extract fractions (Fig. 2C, lanes 3 and 4 and lanes 7 and
8). In thewhole cell lysate, several bandswere detected ofwhich
the largest is 65 kDa (Fig. 2C, lane 1). Because LipYgilv has a
theoretical molecular mass of 51 kDa, this could indicate that
the protein is post-translationally modified. However, because
a similar bandwas observed upon expression of lipYgilv inE. coli
(results not shown), this hypothesis is not likely to be correct. In
agreement with the results obtained by immunoblotting, no
labeling was observed of whole cells in immunogold EM (Fig. 2,
I and J). We attempted to repeat the experiments inM. gilvum
to rule out that LipYgilv is secreted by its natural host, but
despite trying a variety of experimental settings, we failed to
transform M. gilvum. Therefore, secretion was analyzed in
another fast-growing species, i.e. M. smegmatis. Similar to
M. marinum, several bandswere observed in the cell pellet (Fig.
2D, lane 1), but also, in this host, LipYgilv is neither secreted nor
surface-exposed (Fig. 2D, lanes 3 and 4). In conclusion, LipYgilv
is neither exposed on the bacterial surface nor secreted to the
extracellular environment.
The PE and PPE Domains Are Required for Secretion of LipYtub
and LipYmar via ESX-5—To investigate the role of the con-
served PE and PPE domains in ESX-5 secretion, N-terminally
truncated forms of LipYtub andLipYmar lacking the first 125 and
176 aa, respectively (Fig. 1A), were studied. Both mutant pro-
teins were stably produced in the cell lysates of the wild-type
andmutant strains (Fig. 4,A andB, lanes 1 and 5). However, the
absence of bands in the Genapol extracts and culture superna-
tants (Fig. 4,A and B, lanes 3 and 4 and lanes 7 and 8) indicated
that these truncated proteins were not secreted. Detection of
ESAT-6 in culture supernatant fractions confirmed that the
lack of secretion was specific for the LipY homologues. To
exclude the possibility that LipYtub-PE and LipYmar-PPE
were still secreted but could not be recognized by the antise-
rum,we analyzed the lipolytic activity ofM. marinumwild-type
E11 and its ESX-5mutant expressing LipYtub-PE. As shown in
Fig. 3, E11 expressing LipYtub-PE exhibits the same lipase
activity as the wild-type cells. The ESX-5 mutant expressing
LipYtub-PE did not show any activity. Because LipYtub and
LipYmar lacking their N-terminal PE or PPE domains have been
shown to have higher lipase activity than the corresponding
full-length proteins (33), these results confirm that our N-ter-
minally truncated LipY homologues are indeed not secreted.
To test whether the signal peptide of LipYgilv could replace
the PE domain and facilitate secretion of LipYtub to the cell
surface, we exchanged the PE domain (1–101 aa) of LipYtub for
FIGURE3.Lipolyticactivityof cell surface-exposedLipYtub inM. marinum.
Lipid-hydrolyzing activity was determined by measuring the release of p-ni-
trophenol upon incubation of intact cells ofM. marinumwild-type E11 and its
corresponding ESX-5 mutant 7C1 (ESX-5::Tn) overexpressing LipYtub and
LipYtub-PE, with p-nitrophenyl stearate. E11 and 7C1 without plasmids or
carrying the empty vector pSMT3 were included as control strains, so
increases in activity can be specifically attributed to lipase exposed on the
bacterial cell surface. The bars indicate means, and the error bars indicate
standard deviations of two experiments, both performed in triplicate. Abs,
absorbance.
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the signal peptide encoding sequence (1–45 aa) of LipYgilv (Fig.
1A). This chimera was, however, neither secreted nor surface-
exposed upon expression inM. marinum (Fig. 4C, lanes 3 and 4
and lanes 7 and 8). Finally, we also tested whether the PE and
PPE domains of LipYtub and LipYmar without the linker and
lipase domains could be secreted. To this end, we cloned the PE
(1–99 aa) and PPE (1–176 aa) domains of LipYtub and LipYmar
and modified them to express C-terminal HA tags (Fig. 1A)
under the control of the hsp60 promoter. However, upon intro-
duction into M. marinum, neither PELipYtub nor PPELipYmar
could be detected in immunoblots (results not shown), suggest-
ing that they were not stable. In conclusion, these results show
that LipYtub andLipYmar require their respectiveN-terminal PE
and PPE domains for translocation to the cell surface by the
ESX-5 secretion machinery.
LipYgilv Fused to a PE Domain Is Not Secreted—To test
whether the PE domain can target unrelated proteins for ESX-5
secretion, we replaced the signal peptide of LipYgilv (1–45 aa)
with an in-frameN-terminal fusion of the PE domain of LipYtub
(1–103 aa) to the linker and lipase domains of LipYgilv (46–494
aa) (Fig. 1A). However, upon introduction into M. marinum,
this chimeric protein was neither surface-exposed nor secreted
(Fig. 4D, lanes 3 and 4). This led us to believe that (part of) the
linker domain following the PEdomain could be critical. There-
fore, a second fusion was constructed in which the signal pep-
tide and the linker domain of LipYgilv (1–236 aa) were replaced
by the PE domain and the linker domain of LipYtub (1–205 aa)
(Fig. 1A). However, this chimera also failed to be secreted (Fig.
4D, lanes 7 and 8). The first chimeric protein showed the aber-
rant molecular weight features of the LipYgilv protein, whereas
the second construct migrated at the expected molecular
weight (Fig. 4D, lanes 1 and 5), indicating that the linker domain
is responsible for the multiple bands observed with LipYgilv in
SDS-PAGE, of which some are larger than expected.
These results indicate that heterologous proteins cannot eas-
ily be secreted via the ESX-5 pathway. Failure to secrete even a
closely related fusion sequence (44% identity on amino acid
level) suggests that structure or folding kinetics of substrates
may be of importance for ESX-5-dependent translocation.
Processing of Secreted LipYtub—As discussed above, secreted
and surface-exposed LipYtub is detected in a processed form
(Fig. 2A). This could mean either that LipYtub is processed dur-
ing transport or that secreted LipYtub is sensitive to extracellu-
lar proteases. To gain more insight into the mechanism of pro-
cessing, cell lysates ofM. marinum wild-type strain E11 and its
ESX-5 mutant 7C1 overexpressing LipYtub were incubated for
1, 2, 4, and 24 h at 30 °C. No additional processing or degrada-
tion of LipYtub was observed in either strain (Fig. 5A). These
results suggest that LipY is not a protease-sensitive protein,
which indicates that processing of LipYtub is a specific matura-
tion event.
Next, processed LipYtub was isolated from the Genapol
supernatant (Fig. 5B), and the N-terminal sequence was deter-
mined by Edman degradation. The results showed that LipYtub
is cleaved between Gly-149 and Ala-150 (Fig. 5C). The cleavage
position indicates that the PE domain and part of the linker
domain are removed, whereas the intact lipase domain is
retained. The processed protein has a predicted mass of 30.3
FIGURE 4. The N-terminal PE and PPE domains are required for ESX-5
secretion of LipYtub and LipYmar. Immunoblot analysis of truncated and
chimeric forms of the LipY homologues, expressed inM. marinumwt E11 and
its ESX-5 mutant 7C1 (ESX-5::Tn) (A–C) or in E11 alone (D), is shown. A–D,
LipYtub lacking its PE domain (LipYtub-PE) (A), LipYmar lacking its PPE domain
(LipYmar-PPE) (B), and the chimeras in which the PE domain of LipYtub was
replaced by the signal peptide from LipYgilv (SPgilv-LipYtub) (C) or in which the
signal peptide of LipYgilv was replaced by the PE domain of LipYtub (PEtub-
LipYgilv) or the PE and linker domains of LipYtub were fused to the lipase
domainof LipYgilv (PE/linkertub-LipYgilv) (D) were detectedwithHAantiserum.
Equivalent OD units of cell pellets (P), Genapol-treated cells (P), Genapol
surface extracts (S), and 2-fold more culture supernatant (S) are shown.
GroEL2 and ESAT-6 were detected as controls for cell lysis and secretion,
respectively.
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kDa, which correlates well with the observed protein band with
an apparent molecular mass of 28 kDa.
To investigate the nature of the recognition sequence of the
enzyme responsible for processing of LipYtub, we introduced
point mutations in residues surrounding the cleavage site (Fig.
5C). Most strikingly, substitution of the alanine at position 150
for an aspartic acid residue resulted in a complete disappear-
ance of processed LipYtub, whereas a slightly larger cleavage
product was visible (Fig. 5D, lane 11). The S148D and G149D
mutations resulted in reduced production of the 28-kDa band and
accumulation of a slightly larger product, similar to that resulting
from the A150Dmutation (Fig. 5D, lanes 7 and 15). Although the
processing was affected, none of thesemutations affected the sur-
face localization of LipYtub (Fig. 5D, lanes 7, 11, and 15), nor did
theysignificantlyalter the lipaseactivity (resultsnot shown).Three
additional point mutations, P147A, F153A, and D154A, had no
effect on LipYtub processing (not shown).
Taken together, these results suggest that the entire PE
domain and the first 50 amino acids of the linker domain of
LipYtub are removed in a maturation event linked to secretion.
Processing depends on the SGA motif encoded by residues
148–150, but if those residues are mutated, cleavage occurs at
another adjacent site, and secretion and lipase activity are
unaffected.
Expression and Processing of LipYtub in M. tuberculosis and
M. bovis BCG—PE and PPE proteins have previously been
detected on the surface of M. bovis BCG and M. tuberculosis
(21, 25). To investigate whether LipYtub is also surface-exposed
in members of theM. tuberculosis complex, we expressed HA-
tagged LipYtub in M. bovis BCG Copenhagen, M. bovis BCG
Tice, and the M. tuberculosis double auxotroph mutant
mc26020. Although we observed secretion of endogenous
PPE41, a protein that has previously been shown to depend on
ESX-5 (3), LipYtub was not was detected in the Genapol-ex-
tracted fraction or the culture supernatant (Fig. 6A, lanes 3 and
4, for results with M. tuberculosis mc26020; data for M. bovis
BCG strains are not shown). Moreover, unlike inM. marinum,
LipYtub appeared to remain unprocessed (Fig. 6A, lane 1). Con-
sistently, no labeling was observed in whole cell immunogold
EM (not shown).
FIGURE 5. The N terminus is proteolytically removed from secreted LipYtub. A and D, processing of wt and mutated forms of LipYtub was analyzed by
immunoblotting using HA antiserum. GroEL2 was detected as a loading control in A and as a control for bacterial lysis in D. A, no additional processing or
degradationwas observedwhen cell lysates ofM. marinumwt E11 or its ESX-5mutant 7C1 (ESX-5::Tn) expressing LipYtubwere incubated for 1, 2, 4, or 24 h after
sonication. B, Coomassie Brilliant Blue-stained SDS-PAGE gel with Genapol surface extracts of wt M. marinum E11 or E11 expressing LipYtub. Proteins were
transferred to a PVDF membrane, and the band representing processed LipYtub (marked with an arrow in the gel) was analyzed by Edman degradation.
C, LipYtub is processed in the linker domain between residues Gly-149 and Ala-150. Residues altered by site-directedmutagenesis that affected processing are
labeled with asterisks, whereas those that had no effect are marked with triangles. D, The S148D, G149D, and A150D point mutations resulted in (partial)
production of a surface-exposed slightly larger processed form of LipYtub, marked with an asterisk, when expressed inM. marinum strain M
vu. Equal OD units
of cell pellets (P), Genapol-treated cell pellet (P), and Genapol surface extract (S), and 2-fold more culture supernatant (S) are shown.
FIGURE 6. LipYtub processing inM. tuberculosis is triggered during infec-
tion. A, immunoblot analysis of equal OD units of cell pellet (P), Genapol-
treated cell pellet (P ), Genapol surface extract (S ) fractions, and 2-fold
more culture supernatant (S ) of a culture of M. tuberculosis mc26020 har-
boring the pBH10::LipYtub plasmid. B, immunoblot showing cell lysates of
M. tuberculosis (M. tub)mc26020carrying theemptypBH10plasmid (lane1) or
pBH10::LipYtub (lane 2) isolated from THP-1macrophages at day 2 after infec-
tion or from cultures (lanes 3 and 4). A cell lysate showing the processing of
LipYtub in M. marinum (M. mar) strain E11 is included in lane 5. LipYtub was
detected with the HA antibody, GroEL2 was analyzed as control for bacterial
lysis inA and as a loading control in B, and the chromosomally encoded ESX-5
substrate PPE41 was detected as a secretion control in A.
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Because the expression of M. tuberculosis lipY is highly
induced upon infection of host cells (46), we hypothesized that
the lack of secretion in culture could be due to the fact that
additional proteins required for LipY secretion are missing. To
test this possibility, we infected human THP-1 cells, differenti-
ated tomacrophage-like cells in the presence of phorbol 12-my-
ristate 13-acetate, with M. tuberculosis mc26020 and M. bovis
BCGCopenhagen expressingHA-tagged LipYtub. At 1, 2, 3, and
6 days after infection, the THP-1 cells were lysed by Triton
X-100 treatment and centrifuged to collect mycobacteria.
Interestingly, these samples showed the same processing pat-
tern for LipYtub as was observed for this protein upon expres-
sion inM. marinum (see Fig. 6B, lane 2, for results from day 2
after infection withM. tuberculosismc26020; data forM. bovis
BCG are not shown). Together these results indicate that pro-
cessing of LipYtub occurs both inM. marinum and in members
of theM. tuberculosis complex, albeit indicating that in the lat-
ter species, the secretion and/or processing of LipY is induced
during infection.
DISCUSSION
Comparative genomics and phylogenetic analyses indicated
that the evolution of the type VII secretion system ESX-5 pre-
dated the expansion of the PE and PPE gene families in slow-
growing mycobacteria (18). These analyses also showed that
the recently evolved PE_PGRS and PPE_MPTR (major poly-
morphic tandem repeat subfamily of PPE proteins) subfamilies
have probably originated from PE and PPE genes within the
ESX-5 cluster, which resulted in the hypothesis that ESX-5 has
a functional link with the recent expansion of PE and PPE pro-
teins. Recently, we showed that ESX-5 is indeed responsible
for the secretion of various members of the PE_PGRS and
PPE_MPTR protein subfamilies to the cell surface and cul-
ture supernatant of M. marinum (3, 29). In this work, we
report the identification of two novel substrates of the
M. marinum ESX-5 system, the LipY homologues of
M. tuberculosis and M. marinum, which contain a PE and
PPE domain, respectively. Interestingly, the analysis of LipY
allows a further expansion of the original hypothesis. Addi-
tional lipY orthologues were identified in fast-growing
mycobacterial species, namely M. gilvum and M. vanbaale-
nii. These lipY homologues have putative N-terminal signal
sequences instead of a PE or PPE domain. LipYgilv was not
transported to the cell surface, indicating that the PE or PPE
domain is required for surface localization. However, it must
be acknowledged that the localization of LipYgilv could not
be studied in its native host due to problems with transfor-
mation. We would like to propose that LipY homologues in
slow-growing mycobacteria have evolved to secreted pro-
teins by substituting the original signal peptide for PE or PPE
domains and thereby have turned into substrates of the
ESX-5 system (Fig. 7). A remarkable snapshot of this evolu-
tion process can be observed in the genome of M. kansasii,
which has two copies of lipY, one containing a PE domain
and one with a PPE domain.
N-terminally truncated forms of LipYtub and LipYmar were
not transported across the cell envelope, showing that the pres-
ence of a PE or PPE domain is required for secretion via ESX-5.
Unfortunately, our attempt to investigate whether PE and PPE
domains are sufficient for secretion failed because PELipYtub and
PPELipYmar were unstable when expressed alone. However, in
another study, it was shown that the PE domain of PE_PGRS33
can be secreted on its own by ESX-5.3
In M. marinum, surface-exposed LipYtub and LipYmar were
processed, which resulted for LipYtub in the removal of the PE
domain and first half of the linker domain. No further process-
ing or degradationwas observed of LipYtub after extended incu-
bation of M. marinum lysates, indicating that LipY cleavage
results from a specific maturation process, linked to ESX-5
translocation (Fig. 7). Similar patterns ofN-terminal processing
have previously been observed for PE_PGRS and PPE_MPTR
proteins secreted by ESX-5 (29), although the responsible pro-
tease was not identified. This could mean that processing of
ESX-5 substrates is a commonprocess, similar to the removal of
a signal sequence. Interestingly, processing has also been
observed for the ESX-1 substrate EspB (16), which was recently
shown to be cleaved by the ESX-1-encoded protease MycP1
(47). To further investigate the nature of the LipYtub cleavage
site, we altered the neighboring residues using site-directed
mutagenesis. Although introducing point mutations could
block processing at the original cleavage site, the mutations
always resulted in an alternative processing pattern, as is also
observed for signal sequence removal (48, 49). Besides the
removal of the secretion domain, processing could also have a
functional implication.M. tuberculosis utilizes fatty acids as the
principal energy source during the latent stage of infection (50–
52), and it has been shown that it stores fatty acids in the formof
TAGs (51). Dormancy leads to high up-regulation of LipYtub,
whereas a lipYtub mutant has a severely compromised ability
to degrade stored TAGs upon starvation (32). This indicates
that LipY is involved in degradation of intracellular TAGs. In
this study, we show that surface-exposed LipYtub can also
hydrolyze extracellular lipids. LipY may therefore also be
involved in fatty acid acquisition by hydrolyzing host lipids dur-
ing infection.Mishra et al. (33) showed that the lipase activity of
3 A. Cascioferro, M. H. Daleke, W. Bitter, and R. Manganelli, manuscript in
preparation.
FIGURE 7. Model of LipY secretion and processing. Our data support a
model in which the PE or PPE domain of the LipY homologues functions as a
secretion signal that is recognized by the ESX-5 secretion system (1). After
recognition, LipY is translocated across the mycobacterial cell envelope by
the ESX-5 system (2), andduringor after translocation the PEor PPEdomain is
proteolytically removed (3), possibly by the mycosin associated with the
ESX-5 system. Maturation only occurs in strains with a functional ESX-5 sys-
tem, and no further processing is observed during extended incubation of
lysed bacteria. After secretion, processed LipY is loosely associated with the
bacterial surface, where it can hydrolyze TAGs (4). IM, innermembrane;MOM,
mycobacterial outer membrane.
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both LipYtub and LipYmar is significantly higher in the absence
of the PE or PPE domains. Therefore, processing of surface-
exposed LipY will result in increased lipase activity and more
efficient hydrolysis of host lipids.
Intriguingly, LipYtub was found to be neither surface-ex-
posed nor processed when expressed in cultures ofM. tubercu-
losis and M. bovis BCG. However, infection of THP-1 macro-
phages with M. tuberculosis or M. bovis BCG did result in
LipYtub processing, suggesting that the pathway required for
secretion and/or processing in M. tuberculosis complex mem-
bers is activated upon infection of host cells. Endogenous
M. tuberculosis lipY is induced upon infection of macrophages
(46), and it is conceivable that additional proteins required for
LipY secretion and processing are also up-regulated during an
infection. These proteins are not the ESX-5 system itself, which
seems to be constitutively produced. Instead, it could for
instance be a specific chaperone required for secretion or
because proteins secreted via type VII secretion systems are
often secreted as dimers, another ESX-5 substrate (3, 53).
Our data showing that the PE/PPE domain of LipY is essen-
tial for secretion conflict with the results presented in Ref. 33,
where it was shown that localization of LipYtub and LipYmar in
the cell wall of M. smegmatis and M. bovis BCG and on the
bacterial surface of M. bovis BCG is independent of these
domains. Moreover, our analysis in M. tuberculosis and
M. bovis BCG showed that LipY is not surface-exposed when
grown in culture. Although we cannot explain these differ-
ences, we have analyzed the LipY secretion pathway in more
detail using ESX-5 mutants. Immunoblotting and whole cell
immunogold labeling EM showed a clear lack of surface local-
ization of both LipYtub and LipYmar in the ESX-5 mutant, dem-
onstrating that these are indeed ESX-5 substrates. This was
again confirmed in our whole cell lipase assay, in which the
p-nitrophenyl stearate hydrolysis observed with LipYtub in
wild-typeM. marinum was absent in the ESX-5 mutant strain.
Some PE and PPE proteins are encoded in operons (18). One
such couple, consisting of PE25 and PPE41, forms a complex
(54) and is secreted by ESX-5 as a heterodimer.4However, com-
putational predictions suggest thatmany other PE andPPEpro-
teins, including several that are encoded alone in the genome,
also have cognate interaction partners (55). This raises the
hypothesis that PE and PPE proteins are targeted to ESX-5 in
pairs. Experiments are underway in our laboratory to investi-
gate how PE and PPE domains may interact in targeting to
ESX-5 and to identify the residues within the PE and PPE
domains that constitute the ESX-5 secretion signal.
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